Lv5
948 积分 2023-06-15 加入
ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients
23天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Cancer incidence and mortality in China, 2022
1个月前
已关闭
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
1个月前
已完结
Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data
1个月前
已完结
Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis
1个月前
已完结
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial
1个月前
已完结
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Personalized and HPV cancer vaccines in head and neck squamous cell carcinoma: from concept to clinical implementation
2个月前
已完结
皖公网安备34019202002308
